TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Kivo Health has raised $10 million in a Series A round led by Allumia Ventures, bringing its total financing to $16 million. The Seattle company plans to expand its virtual home-care program nationally and says it aims to reach tens of thousands of patients within two years; the timeline and expansion details have not been disclosed.
Seattle-based Kivo Health has raised $10 million in Series A financing to expand its virtual home-care program for people with chronic lung disease, the company said. The round brings Kivo’s total financing to $16 million and is intended to support a nationwide expansion, according to reporting by Home Health Care News.
Allumia Ventures led the round, with participation from Corewell Health Ventures, Y Combinator, Heuristic Capital and MassMutual Ventures, Home Health Care News reported. The report confirmed the funding amount and investor list and said the funding would support national expansion.
Kivo provides AI-powered virtual care at home, beginning with treatment for chronic obstructive pulmonary disease, or COPD. Its program pairs home-use equipment and individual treatment plans with remote sessions led by respiratory therapists. The company says the service is designed to help patients manage symptoms between clinical visits and receive earlier intervention.
According to Kivo’s website, enrolled patients receive a COPD management kit that includes a tablet, oxygen monitor and exercise bands. They first meet virtually with a respiratory therapist to assess symptoms and develop a plan. Patients then join small-group sessions with therapists twice a week for nine weeks, covering breathing techniques, targeted exercises and COPD management resources.
Funding Supports Broader Patient Reach
The financing gives Kivo capital to pursue growth in a care model aimed at people who may need ongoing support outside appointments. COPD management can involve repeated clinical contact, and the company’s approach puts scheduled therapist sessions and monitoring tools in patients’ homes. Whether that approach changes outcomes or spending at a larger scale remains a question for future results.
Kivo’s chief executive said the company plans to expand nationwide and reach tens of thousands of patients within two years. That is a stated goal, not a reported enrollment result. If achieved, it would mark a substantial increase in the reach of the service; the company has not published a detailed expansion schedule or patient target by market.
The company also says its program is covered by Medicare, Medicaid and major health plans, including UnitedHealthcare, Humana, Blue Cross, Aetna and Priority Health. Insurance coverage may affect who can access the service, although the source report does not detail eligibility criteria, patient costs or coverage terms. Kivo says it may adapt its model for other high-cost chronic illnesses, but it has not named conditions or a launch timetable.
Products Worth Considering
Fitbit Sense Advanced Smartwatch – Sage Grey/Silver (One Size, S & L Bands Included)
Fitbit Versa 2 Health and Fitness Smartwatch with Bonus Bands
Blueair Blue Pure 511i Max Air Purifier for Home and Bedroom
As an affiliate, we earn on qualifying purchases.
How Kivo’s COPD Program Works
Kivo says its care model helps patients manage COPD between clinical visits. Its program includes a home kit and virtual sessions. The company describes sessions covering breathing techniques, targeted exercises and COPD management resources. The source report does not describe the specific AI tools used or how they inform treatment.
In an email to Home Health Care News, co-founder and CEO Victor Sadauskas said Kivo had delivered tens of thousands of sessions and provided thousands of patients access to care. He also said the company’s service saves health plans money by reducing unnecessary hospitalizations, emergency-room visits and nursing-home days. Those figures and savings claims were attributed to the company.
Kivo claims its program reduces total health spending by $8,245 per member per year. That figure is the company’s stated estimate, as reported by Home Health Care News.
“We have delivered tens of thousands of sessions, providing thousands of patients access to care that improves symptoms and saves health plans money by reducing unnecessary hospitalizations, ER visits and nursing home days.”
— Victor Sadauskas, Kivo Health co-founder and CEO, in an email to Home Health Care News
Savings and Expansion Details Pending
The source report identifies the investors in the round and says the funding will support national expansion. It does not provide a detailed breakdown of how the capital will be allocated.
Kivo’s annual savings figure of $8,245 per member is a company-reported claim. The source report presents the figure without further details about how it was calculated.
Kivo says it has provided thousands of patients access to care and plans to expand nationwide. The source report does not give a detailed account of the rollout. The company also says it intends to extend its model to other high-cost chronic illnesses, without specifying a timetable. Coverage is listed across public programs and commercial plans.
National Rollout and New Conditions
Kivo says it will use the Series A funding to expand nationwide and aims to serve tens of thousands of patients over the next two years.
The company has also said it intends to extend its care model beyond COPD to other high-cost chronic illnesses. Kivo has not specified which conditions it intends to address or when it plans to expand beyond COPD. Future updates on enrollment, insurance access and independently reported outcomes could help clarify how the program performs as it grows.
Key Questions
How much did Kivo Health raise?
Kivo raised $10 million in Series A financing, bringing its reported total financing to $16 million.
Who led the funding round?
Allumia Ventures led the round. Corewell Health Ventures, Y Combinator, Heuristic Capital and MassMutual Ventures also participated, according to Home Health Care News.
What care does Kivo provide?
Kivo’s program currently focuses on virtual home care for people with COPD. It combines a home kit, a personalized plan and remote respiratory-therapy sessions, including twice-weekly small-group sessions over nine weeks, according to the company’s website.
Does Kivo’s program reduce health-care costs?
Kivo claims its program reduces spending by $8,245 per member per year. The source report does not provide independent verification or the methodology behind that estimate, so it should be treated as a company claim.
What is Kivo planning next?
The company says it plans to expand nationwide, with a goal of reaching tens of thousands of patients within two years, and to explore care programs for other high-cost chronic illnesses. Specific locations, conditions and launch dates have not been announced.
Source: rss
